+关注
MustSureHuat
暂无个人介绍
IP属地:未知
3
关注
3
粉丝
0
主题
0
勋章
主贴
热门
MustSureHuat
2021-12-16
😃 what will happen today?
MustSureHuat
2021-11-02
Nice game
@小虎活动:[Halloween Game] Trade or Treat!
MustSureHuat
2021-11-01
Nice game serious
@小虎活动:[Halloween Game] Trade or Treat!
MustSureHuat
2021-10-31
Where the free chance
@小虎活动:[Halloween Game] Trade or Treat!
MustSureHuat
2021-10-31
Wow what a game
MustSureHuat
2021-10-29
Power game
@小虎活动:[Halloween Game] Trade or Treat!
MustSureHuat
2021-04-05
$Labor Smart Inc(LTNC)$
Scared money makes no money
MustSureHuat
2021-01-22
Wow
Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote>
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3565712668199704","uuid":"3565712668199704","gmtCreate":1602618645278,"gmtModify":1603681887974,"name":"MustSureHuat","pinyin":"mustsurehuat","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":3,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":690141307,"gmtCreate":1639649425029,"gmtModify":1639649425149,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"😃 what will happen today?","listText":"😃 what will happen today?","text":"😃 what will happen today?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690141307","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843027465,"gmtCreate":1635783811261,"gmtModify":1635783811261,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Nice game","listText":"Nice game","text":"Nice game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843027465","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849019312,"gmtCreate":1635700623817,"gmtModify":1635700623817,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Nice game serious","listText":"Nice game serious","text":"Nice game serious","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849019312","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840558937,"gmtCreate":1635663140655,"gmtModify":1635663140655,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Where the free chance ","listText":"Where the free chance ","text":"Where the free chance","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840558937","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840551300,"gmtCreate":1635663009405,"gmtModify":1635663022455,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Wow what a game ","listText":"Wow what a game ","text":"Wow what a game","images":[{"img":"https://static.tigerbbs.com/a05637bdbb43627d9c8989e68b4dcd6a","width":"1242","height":"1842"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840551300","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":857937672,"gmtCreate":1635501496383,"gmtModify":1635501724827,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Power game","listText":"Power game","text":"Power game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857937672","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349429480,"gmtCreate":1617633127940,"gmtModify":1631886944503,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LTNC\">$Labor Smart Inc(LTNC)$</a>Scared money makes no money ","listText":"<a href=\"https://laohu8.com/S/LTNC\">$Labor Smart Inc(LTNC)$</a>Scared money makes no money ","text":"$Labor Smart Inc(LTNC)$Scared money makes no money","images":[{"img":"https://static.tigerbbs.com/182368b772814659e365f557a30d7fc1","width":"1242","height":"2385"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":2,"link":"https://laohu8.com/post/349429480","isVote":1,"tweetType":1,"viewCount":1004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":310897244,"gmtCreate":1611301038188,"gmtModify":1703749529984,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/310897244","repostId":"2105459536","repostType":4,"repost":{"id":"2105459536","kind":"news","pubTimestamp":1611300933,"share":"https://www.laohu8.com/m/news/2105459536?lang=zh_CN&edition=full","pubTime":"2021-01-22 15:35","market":"us","language":"en","title":"Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2105459536","media":"Zacks","summary":"Shares ofGilead Sciences, Inc. are up 19.3% in the past month. The company, had an eventful 2020 and","content":"<p>Shares of<b>Gilead Sciences, Inc</b>. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.</p><p><blockquote>本公司之股份<b>吉利德科学公司</b>过去一个月上涨了19.3%。该公司经历了多事的2020年,并因其冠状病毒治疗药物Veklury(瑞德西韦)而成为人们关注的焦点。FDA完全批准Veklury用于治疗COVID-19患者,欧盟委员会(“EC”)也授予其有条件上市许可。</blockquote></p><p> The stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.</p><p><blockquote>该股去年上涨了7.2%,而该行业的增长率为13.9%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/af3ba6e3f673d6fd0f236d1fd5a528aa\" tg-width=\"620\" tg-height=\"283\"></p><p><blockquote></blockquote></p><p> Last week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.</p><p><blockquote>上周,由于冠状病毒大流行的恶化推动了Veklury的销售,该公司上调了2020年年度销售指引。目前预计2020年产品总销售额为24.3-243.5亿美元,高于之前指导的23-235亿美元。鉴于最近的COVID-19激增,住院率和治疗率高于预期,Veklury销售额出现增长。Veklury销售额预计为2.8-28.25亿美元。</blockquote></p><p> Total product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.</p><p><blockquote>考虑到Biktarvy潜在的强劲吸收,不包括Veklury的产品总销售额预计为21.5-215.25亿美元,部分被Truvada在美国独家经营权的丧失以及COVID-19主要对吉利德暴露前预防(“PrEP”)特许经营权和慢性丙型肝炎病毒(“HCV”)特许经营权的影响所抵消。</blockquote></p><p> While Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines from<b>Pfizer</b> and others might lead to a decline in sales eventually.</p><p><blockquote>虽然随着过去几个月大流行的恶化,Veklury的销售强劲,但疫苗的推出<b>辉瑞</b>和其他可能最终导致销售额下降。</blockquote></p><p> Nevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes of<b>Glaxo</b>. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.</p><p><blockquote>尽管如此,尽管面临来自以下公司的激烈竞争,吉利德仍可能保持以Biktarvy为首的强大艾滋病毒专营权的势头<b>葛兰素</b>Descovy(恩曲他滨200 mg和替诺福韦艾拉酚胺25 mg片剂;F/TAF)作为一种预防选择的标签扩展促进了该治疗的销售。FDA早些时候还将Truvada作为PrEP的适应症扩展到了高危青少年。新疗法的批准加强了特许经营权。</blockquote></p><p> We remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.</p><p><blockquote>我们提醒投资者,其曾经利润丰厚的丙肝专营权销售额大幅下降,促使其将重点放在HIV专营权、Yescarta和其他较新的途径上。</blockquote></p><p> Gilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.</p><p><blockquote>吉利德正在向肿瘤领域多元化发展。为此,它以约210亿美元收购了Immunomedics,并达成战略合作,进军利润丰厚的肿瘤领域。2020年4月,吉利德以49亿美元收购了Forty Seven,并获得了magrolimab,这是一种正在临床开发中的研究性单克隆抗体,用于治疗多种血液癌症。吉利德还收购了Pionyr Immunotherapeutics,Inc.49.9%的股权,这是一家在免疫肿瘤学领域追求新型生物学的私营公司。</blockquote></p><p> It has also collaborated with<b>Novo Nordisk</b> for developing treatments for non-alcoholic steatohepatitis (NASH).</p><p><blockquote>它还与<b>诺和诺德</b>用于开发非酒精性脂肪性肝炎(NASH)的治疗方法。</blockquote></p><p> <b>Biggest Tech Breakthrough in a Generation</b></p><p><blockquote><b>一代人最大的技术突破</b></blockquote></p><p> Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.</p><p><blockquote>成为这种新型设备的早期投资者之一,专家称这种设备对社会的影响可能不亚于电的发现。目前的技术很快就会过时,被这些新设备所取代。在此过程中,预计将创造2200万个就业岗位并产生12.3万亿美元的活动。</blockquote></p><p> A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.</p><p><blockquote>随着这项新技术的加速推出,少数股票可能会飙升最多。早期投资者可能会看到类似于20世纪90年代购买微软的收益。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2021-01-22 15:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of<b>Gilead Sciences, Inc</b>. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.</p><p><blockquote>本公司之股份<b>吉利德科学公司</b>过去一个月上涨了19.3%。该公司经历了多事的2020年,并因其冠状病毒治疗药物Veklury(瑞德西韦)而成为人们关注的焦点。FDA完全批准Veklury用于治疗COVID-19患者,欧盟委员会(“EC”)也授予其有条件上市许可。</blockquote></p><p> The stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.</p><p><blockquote>该股去年上涨了7.2%,而该行业的增长率为13.9%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/af3ba6e3f673d6fd0f236d1fd5a528aa\" tg-width=\"620\" tg-height=\"283\"></p><p><blockquote></blockquote></p><p> Last week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.</p><p><blockquote>上周,由于冠状病毒大流行的恶化推动了Veklury的销售,该公司上调了2020年年度销售指引。目前预计2020年产品总销售额为24.3-243.5亿美元,高于之前指导的23-235亿美元。鉴于最近的COVID-19激增,住院率和治疗率高于预期,Veklury销售额出现增长。Veklury销售额预计为2.8-28.25亿美元。</blockquote></p><p> Total product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.</p><p><blockquote>考虑到Biktarvy潜在的强劲吸收,不包括Veklury的产品总销售额预计为21.5-215.25亿美元,部分被Truvada在美国独家经营权的丧失以及COVID-19主要对吉利德暴露前预防(“PrEP”)特许经营权和慢性丙型肝炎病毒(“HCV”)特许经营权的影响所抵消。</blockquote></p><p> While Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines from<b>Pfizer</b> and others might lead to a decline in sales eventually.</p><p><blockquote>虽然随着过去几个月大流行的恶化,Veklury的销售强劲,但疫苗的推出<b>辉瑞</b>和其他可能最终导致销售额下降。</blockquote></p><p> Nevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes of<b>Glaxo</b>. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.</p><p><blockquote>尽管如此,尽管面临来自以下公司的激烈竞争,吉利德仍可能保持以Biktarvy为首的强大艾滋病毒专营权的势头<b>葛兰素</b>Descovy(恩曲他滨200 mg和替诺福韦艾拉酚胺25 mg片剂;F/TAF)作为一种预防选择的标签扩展促进了该治疗的销售。FDA早些时候还将Truvada作为PrEP的适应症扩展到了高危青少年。新疗法的批准加强了特许经营权。</blockquote></p><p> We remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.</p><p><blockquote>我们提醒投资者,其曾经利润丰厚的丙肝专营权销售额大幅下降,促使其将重点放在HIV专营权、Yescarta和其他较新的途径上。</blockquote></p><p> Gilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.</p><p><blockquote>吉利德正在向肿瘤领域多元化发展。为此,它以约210亿美元收购了Immunomedics,并达成战略合作,进军利润丰厚的肿瘤领域。2020年4月,吉利德以49亿美元收购了Forty Seven,并获得了magrolimab,这是一种正在临床开发中的研究性单克隆抗体,用于治疗多种血液癌症。吉利德还收购了Pionyr Immunotherapeutics,Inc.49.9%的股权,这是一家在免疫肿瘤学领域追求新型生物学的私营公司。</blockquote></p><p> It has also collaborated with<b>Novo Nordisk</b> for developing treatments for non-alcoholic steatohepatitis (NASH).</p><p><blockquote>它还与<b>诺和诺德</b>用于开发非酒精性脂肪性肝炎(NASH)的治疗方法。</blockquote></p><p> <b>Biggest Tech Breakthrough in a Generation</b></p><p><blockquote><b>一代人最大的技术突破</b></blockquote></p><p> Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.</p><p><blockquote>成为这种新型设备的早期投资者之一,专家称这种设备对社会的影响可能不亚于电的发现。目前的技术很快就会过时,被这些新设备所取代。在此过程中,预计将创造2200万个就业岗位并产生12.3万亿美元的活动。</blockquote></p><p> A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.</p><p><blockquote>随着这项新技术的加速推出,少数股票可能会飙升最多。早期投资者可能会看到类似于20世纪90年代购买微软的收益。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.zacks.com/stock/news/1250053/gilead-gild-up-19-in-the-past-month-what-lies-ahead\">Zacks</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学"},"source_url":"https://www.zacks.com/stock/news/1250053/gilead-gild-up-19-in-the-past-month-what-lies-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2105459536","content_text":"Shares ofGilead Sciences, Inc. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.\nThe stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.\n\nLast week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.\nTotal product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.\nWhile Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines fromPfizer and others might lead to a decline in sales eventually.\nNevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes ofGlaxo. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.\nWe remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.\nGilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.\nIt has also collaborated withNovo Nordisk for developing treatments for non-alcoholic steatohepatitis (NASH).\nBiggest Tech Breakthrough in a Generation\nBe among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.\nA select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.","news_type":1,"symbols_score_info":{"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":349429480,"gmtCreate":1617633127940,"gmtModify":1631886944503,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LTNC\">$Labor Smart Inc(LTNC)$</a>Scared money makes no money ","listText":"<a href=\"https://laohu8.com/S/LTNC\">$Labor Smart Inc(LTNC)$</a>Scared money makes no money ","text":"$Labor Smart Inc(LTNC)$Scared money makes no money","images":[{"img":"https://static.tigerbbs.com/182368b772814659e365f557a30d7fc1","width":"1242","height":"2385"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":2,"link":"https://laohu8.com/post/349429480","isVote":1,"tweetType":1,"viewCount":1004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":310897244,"gmtCreate":1611301038188,"gmtModify":1703749529984,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/310897244","repostId":"2105459536","repostType":4,"repost":{"id":"2105459536","kind":"news","pubTimestamp":1611300933,"share":"https://www.laohu8.com/m/news/2105459536?lang=zh_CN&edition=full","pubTime":"2021-01-22 15:35","market":"us","language":"en","title":"Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2105459536","media":"Zacks","summary":"Shares ofGilead Sciences, Inc. are up 19.3% in the past month. The company, had an eventful 2020 and","content":"<p>Shares of<b>Gilead Sciences, Inc</b>. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.</p><p><blockquote>本公司之股份<b>吉利德科学公司</b>过去一个月上涨了19.3%。该公司经历了多事的2020年,并因其冠状病毒治疗药物Veklury(瑞德西韦)而成为人们关注的焦点。FDA完全批准Veklury用于治疗COVID-19患者,欧盟委员会(“EC”)也授予其有条件上市许可。</blockquote></p><p> The stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.</p><p><blockquote>该股去年上涨了7.2%,而该行业的增长率为13.9%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/af3ba6e3f673d6fd0f236d1fd5a528aa\" tg-width=\"620\" tg-height=\"283\"></p><p><blockquote></blockquote></p><p> Last week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.</p><p><blockquote>上周,由于冠状病毒大流行的恶化推动了Veklury的销售,该公司上调了2020年年度销售指引。目前预计2020年产品总销售额为24.3-243.5亿美元,高于之前指导的23-235亿美元。鉴于最近的COVID-19激增,住院率和治疗率高于预期,Veklury销售额出现增长。Veklury销售额预计为2.8-28.25亿美元。</blockquote></p><p> Total product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.</p><p><blockquote>考虑到Biktarvy潜在的强劲吸收,不包括Veklury的产品总销售额预计为21.5-215.25亿美元,部分被Truvada在美国独家经营权的丧失以及COVID-19主要对吉利德暴露前预防(“PrEP”)特许经营权和慢性丙型肝炎病毒(“HCV”)特许经营权的影响所抵消。</blockquote></p><p> While Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines from<b>Pfizer</b> and others might lead to a decline in sales eventually.</p><p><blockquote>虽然随着过去几个月大流行的恶化,Veklury的销售强劲,但疫苗的推出<b>辉瑞</b>和其他可能最终导致销售额下降。</blockquote></p><p> Nevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes of<b>Glaxo</b>. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.</p><p><blockquote>尽管如此,尽管面临来自以下公司的激烈竞争,吉利德仍可能保持以Biktarvy为首的强大艾滋病毒专营权的势头<b>葛兰素</b>Descovy(恩曲他滨200 mg和替诺福韦艾拉酚胺25 mg片剂;F/TAF)作为一种预防选择的标签扩展促进了该治疗的销售。FDA早些时候还将Truvada作为PrEP的适应症扩展到了高危青少年。新疗法的批准加强了特许经营权。</blockquote></p><p> We remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.</p><p><blockquote>我们提醒投资者,其曾经利润丰厚的丙肝专营权销售额大幅下降,促使其将重点放在HIV专营权、Yescarta和其他较新的途径上。</blockquote></p><p> Gilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.</p><p><blockquote>吉利德正在向肿瘤领域多元化发展。为此,它以约210亿美元收购了Immunomedics,并达成战略合作,进军利润丰厚的肿瘤领域。2020年4月,吉利德以49亿美元收购了Forty Seven,并获得了magrolimab,这是一种正在临床开发中的研究性单克隆抗体,用于治疗多种血液癌症。吉利德还收购了Pionyr Immunotherapeutics,Inc.49.9%的股权,这是一家在免疫肿瘤学领域追求新型生物学的私营公司。</blockquote></p><p> It has also collaborated with<b>Novo Nordisk</b> for developing treatments for non-alcoholic steatohepatitis (NASH).</p><p><blockquote>它还与<b>诺和诺德</b>用于开发非酒精性脂肪性肝炎(NASH)的治疗方法。</blockquote></p><p> <b>Biggest Tech Breakthrough in a Generation</b></p><p><blockquote><b>一代人最大的技术突破</b></blockquote></p><p> Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.</p><p><blockquote>成为这种新型设备的早期投资者之一,专家称这种设备对社会的影响可能不亚于电的发现。目前的技术很快就会过时,被这些新设备所取代。在此过程中,预计将创造2200万个就业岗位并产生12.3万亿美元的活动。</blockquote></p><p> A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.</p><p><blockquote>随着这项新技术的加速推出,少数股票可能会飙升最多。早期投资者可能会看到类似于20世纪90年代购买微软的收益。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGilead (GILD) Up 19% in the Past Month: What Lies Ahead?<blockquote>吉利德(GILD)过去一个月上涨19%:未来会怎样?</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2021-01-22 15:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of<b>Gilead Sciences, Inc</b>. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.</p><p><blockquote>本公司之股份<b>吉利德科学公司</b>过去一个月上涨了19.3%。该公司经历了多事的2020年,并因其冠状病毒治疗药物Veklury(瑞德西韦)而成为人们关注的焦点。FDA完全批准Veklury用于治疗COVID-19患者,欧盟委员会(“EC”)也授予其有条件上市许可。</blockquote></p><p> The stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.</p><p><blockquote>该股去年上涨了7.2%,而该行业的增长率为13.9%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/af3ba6e3f673d6fd0f236d1fd5a528aa\" tg-width=\"620\" tg-height=\"283\"></p><p><blockquote></blockquote></p><p> Last week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.</p><p><blockquote>上周,由于冠状病毒大流行的恶化推动了Veklury的销售,该公司上调了2020年年度销售指引。目前预计2020年产品总销售额为24.3-243.5亿美元,高于之前指导的23-235亿美元。鉴于最近的COVID-19激增,住院率和治疗率高于预期,Veklury销售额出现增长。Veklury销售额预计为2.8-28.25亿美元。</blockquote></p><p> Total product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.</p><p><blockquote>考虑到Biktarvy潜在的强劲吸收,不包括Veklury的产品总销售额预计为21.5-215.25亿美元,部分被Truvada在美国独家经营权的丧失以及COVID-19主要对吉利德暴露前预防(“PrEP”)特许经营权和慢性丙型肝炎病毒(“HCV”)特许经营权的影响所抵消。</blockquote></p><p> While Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines from<b>Pfizer</b> and others might lead to a decline in sales eventually.</p><p><blockquote>虽然随着过去几个月大流行的恶化,Veklury的销售强劲,但疫苗的推出<b>辉瑞</b>和其他可能最终导致销售额下降。</blockquote></p><p> Nevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes of<b>Glaxo</b>. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.</p><p><blockquote>尽管如此,尽管面临来自以下公司的激烈竞争,吉利德仍可能保持以Biktarvy为首的强大艾滋病毒专营权的势头<b>葛兰素</b>Descovy(恩曲他滨200 mg和替诺福韦艾拉酚胺25 mg片剂;F/TAF)作为一种预防选择的标签扩展促进了该治疗的销售。FDA早些时候还将Truvada作为PrEP的适应症扩展到了高危青少年。新疗法的批准加强了特许经营权。</blockquote></p><p> We remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.</p><p><blockquote>我们提醒投资者,其曾经利润丰厚的丙肝专营权销售额大幅下降,促使其将重点放在HIV专营权、Yescarta和其他较新的途径上。</blockquote></p><p> Gilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.</p><p><blockquote>吉利德正在向肿瘤领域多元化发展。为此,它以约210亿美元收购了Immunomedics,并达成战略合作,进军利润丰厚的肿瘤领域。2020年4月,吉利德以49亿美元收购了Forty Seven,并获得了magrolimab,这是一种正在临床开发中的研究性单克隆抗体,用于治疗多种血液癌症。吉利德还收购了Pionyr Immunotherapeutics,Inc.49.9%的股权,这是一家在免疫肿瘤学领域追求新型生物学的私营公司。</blockquote></p><p> It has also collaborated with<b>Novo Nordisk</b> for developing treatments for non-alcoholic steatohepatitis (NASH).</p><p><blockquote>它还与<b>诺和诺德</b>用于开发非酒精性脂肪性肝炎(NASH)的治疗方法。</blockquote></p><p> <b>Biggest Tech Breakthrough in a Generation</b></p><p><blockquote><b>一代人最大的技术突破</b></blockquote></p><p> Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.</p><p><blockquote>成为这种新型设备的早期投资者之一,专家称这种设备对社会的影响可能不亚于电的发现。目前的技术很快就会过时,被这些新设备所取代。在此过程中,预计将创造2200万个就业岗位并产生12.3万亿美元的活动。</blockquote></p><p> A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.</p><p><blockquote>随着这项新技术的加速推出,少数股票可能会飙升最多。早期投资者可能会看到类似于20世纪90年代购买微软的收益。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.zacks.com/stock/news/1250053/gilead-gild-up-19-in-the-past-month-what-lies-ahead\">Zacks</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学"},"source_url":"https://www.zacks.com/stock/news/1250053/gilead-gild-up-19-in-the-past-month-what-lies-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2105459536","content_text":"Shares ofGilead Sciences, Inc. are up 19.3% in the past month. The company, had an eventful 2020 and was in the spotlight due to its coronavirus treatment, Veklury (remdesivir). The FDA granted full approval to Veklury for the treatment of patients with COVID-19 and the European Commission (“EC”) also granted conditional Marketing Authorization for the same.\nThe stock has gained 7.2% in the past year compared with theindustry’s growth of 13.9%.\n\nLast week, the companyincreasedits annual sales guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury. Total product sales are now projected to be $24.3-$24.35 billion for 2020, up from the previous guidance of $23-$23.5 billion. Veklury sales witnessed growth as hospitalization and treatment rates were higher than expected, given the most recent COVID-19 surge. Veklury sales are estimated at $2.8-$2.825 billion.\nTotal product sales, excluding Veklury, are projected to be $21.5-$21.525 billion, considering the underlying strong Biktarvy uptake, partially offset by the loss of exclusivity of Truvada in the United States and the impact of COVID-19 primarily on Gilead’s pre-exposure prophylaxis (“PrEP”) franchise and chronic hepatitis C virus (“HCV”) franchise.\nWhile Veklury sales were strong as the pandemic worsened in the last couple of months, the rollout of vaccines fromPfizer and others might lead to a decline in sales eventually.\nNevertheless, Gilead is likely to maintain momentum on its strong HIV franchise led by Biktarvy despite stiff competition from the likes ofGlaxo. The label expansion of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) as a prevention option has boosted sales of the treatment. The FDA had earlier also extended the indication for Truvada as PrEP to include at-risk adolescents. Approval of new therapies has strengthened the franchise.\nWe remind investors that the massive decline in sales of its once lucrative HCV franchise has prompted it to focus on the HIV franchise, Yescarta and other newer avenues.\nGilead is diversifying into the oncology space. To that end, it acquired Immunomedics for approximately $21 billion and entered into strategic collaborations to foray into the lucrative oncology space. In April 2020, Gilead acquired Forty Seven for $4.9 billion and gained magrolimab, an investigational monoclonal antibody in clinical development for the treatment of a number of hematological cancers. Gilead also acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc., a privately-held company pursuing novel biology in the field of immuno-oncology.\nIt has also collaborated withNovo Nordisk for developing treatments for non-alcoholic steatohepatitis (NASH).\nBiggest Tech Breakthrough in a Generation\nBe among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.\nA select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s.","news_type":1,"symbols_score_info":{"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690141307,"gmtCreate":1639649425029,"gmtModify":1639649425149,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"😃 what will happen today?","listText":"😃 what will happen today?","text":"😃 what will happen today?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690141307","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843027465,"gmtCreate":1635783811261,"gmtModify":1635783811261,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Nice game","listText":"Nice game","text":"Nice game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843027465","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849019312,"gmtCreate":1635700623817,"gmtModify":1635700623817,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Nice game serious","listText":"Nice game serious","text":"Nice game serious","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849019312","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840558937,"gmtCreate":1635663140655,"gmtModify":1635663140655,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Where the free chance ","listText":"Where the free chance ","text":"Where the free chance","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840558937","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840551300,"gmtCreate":1635663009405,"gmtModify":1635663022455,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Wow what a game ","listText":"Wow what a game ","text":"Wow what a game","images":[{"img":"https://static.tigerbbs.com/a05637bdbb43627d9c8989e68b4dcd6a","width":"1242","height":"1842"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840551300","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":857937672,"gmtCreate":1635501496383,"gmtModify":1635501724827,"author":{"id":"3565712668199704","authorId":"3565712668199704","name":"MustSureHuat","avatar":"https://static.tigerbbs.com/4f5bd03af999026dd9c0f4255c421c3e","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565712668199704","idStr":"3565712668199704"},"themes":[],"htmlText":"Power game","listText":"Power game","text":"Power game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857937672","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap here to play the Halloween game, and you stand a chance to win various rewards! </a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}